Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1086006
Abstract: Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant haematological diseases. Despite continuous improvements in pre- and post-transplantation procedures, the applicability of allo-HSCT is limited by life-threatening complications such as graft-versus-host disease…
read more here.
Keywords:
immunomodulatory treatment;
gvhd;
treatment modality;
treatment ... See more keywords